Effectiveness of anthocyanin-rich foods on bone remodeling biomarkers of middle-aged and older adults at risk of osteoporosis: a systematic review, meta-analysis …
Context Current osteoporosis pharmacological treatment has undesirable side effects. There
is increasing focus on naturally derived food substances that contain phytonutrients with …
is increasing focus on naturally derived food substances that contain phytonutrients with …
Efficacy and safety of romosozumab: a meta-analysis of placebo-controlled trials
T Kobayashi, M Hara, C Shimanoe, T Morimoto… - Journal of Bone and …, 2024 - Springer
Materials and methods PubMed, Google Scholar, and ClinicalTrials. gov were searched for
relevant placebo-controlled trials (as of January 1, 2024). Percent change in bone mineral …
relevant placebo-controlled trials (as of January 1, 2024). Percent change in bone mineral …
Monthly treatment with romosozumab for one year increases bone mineral at the hip, but not the knee, in women with chronic spinal cord injury
LE Crack, N Simonian, TJ Schnitzer, WB Edwards - JBMR Plus, 2024 - academic.oup.com
Bone loss below the level of neurological lesion is a well-known complication of spinal cord
injury (SCI). To date, most research has focused on pharmaceutical intervention using …
injury (SCI). To date, most research has focused on pharmaceutical intervention using …
Age-related disease: Bones
JN Farr, A Chandra - Aging, 2024 - Elsevier
Age-related disease: Bones - ScienceDirect Skip to main contentSkip to article Elsevier logo
Journals & Books Search RegisterSign in View PDF Download full book Search ScienceDirect …
Journals & Books Search RegisterSign in View PDF Download full book Search ScienceDirect …
[HTML][HTML] Clinical Studies On Romosozumab: An Alternative For Individuals With A High Risk Of Osteoporotic Fractures: A Current Concepts Review (Part II)
EC Rodriguez-Merchan, A Moreno-Garcia… - …, 2023 - surgicoll.scholasticahq.com
Romosumab (ROMO) should be used to treat postmenopausal women with osteoporosis at
high fracture risk after carefully considering the cardiovascular status and the risk/benefit …
high fracture risk after carefully considering the cardiovascular status and the risk/benefit …
[HTML][HTML] Диагностика и лечение остеопороза: смена парадигмы
КГ Лобанова, ФО Ушанова - FOCUS. Эндокринология, 2024 - cyberleninka.ru
Основным клиническим проявлением остеопороза (ОП) является низкоэнергетичный
перелом. Перелом, в свою очередь, ассоциирован с высоким риском инвалидизации и …
перелом. Перелом, в свою очередь, ассоциирован с высоким риском инвалидизации и …
What's New in Osteoporosis: Emphasis on the Aging Athlete
The contemporary treatment of osteoporosis has seen tremendous evolution. Today, we
have access to powerful biologic agents for the treatment of osteoporosis and an improved …
have access to powerful biologic agents for the treatment of osteoporosis and an improved …
[引用][C] Side effects of drugs for metabolic bone disease
CN Walker, JT Feiner, MKM North, EA Masser… - 2023 - Elsevier